This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Cholpon Tilegenova, Ph.D
Senior Principal Scientist, Biologics Discovery at Johnson & Johnson Innovative Medicine
Speaker

Profile

Cholpon Tilegenova Ph.D. is a Senior Principal Scientist in the Biologics Discovery Department at J&J Innovative Medicine. Her focus is on multi-specific antibody design. She is a co-inventor of ProAla bispecific antibody platform leading to 3 new clinical starts. Cholpon earned her Ph.D. in Molecular Biophysics from Texas Tech University Health Sciences Center and completed postdoctoral training at Genentech, Paul Carter’s lab. Cholpon has published 9 peer reviewed papers and inventor of 3 applied patents. Cholpon travels for food and enjoys long walks.

Agenda Sessions

  • Folding-mediated Secretion of Pure Bispecific Antibodies

    10:20